lobbying_activities: 1371669
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1371669 | 51182f00-99ee-4ef5-9ec8-a3376bec8d06 | Q1 | MEHLMAN CONSULTING, INC. | 284950 | AMERICAN CLINICAL LABORATORY ASSOCIATION | 2013 | first_quarter | MED | Health reform law implementation issues including application of medical device tax to clinical laboratory tests and laboratory fee schedule. In-office ancillary services exception to Stark Law. FDA oversight of laboratory-developed tests. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office | 80000 | 0 | 0 | 2013-04-15T10:18:14.130000-04:00 |